Ogury aims to create more impactful ads using data on the behaviour of smartphone and tablet users across multiple apps, brands and websites. Its vision is centred around personalised data for a better user experience. The rise in content consumption in recent years—which has only accelerated during the pandemic—no doubt has had an impact on the success of the business.
The adtech scaleup has received £69m in equity funding across five rounds since its launch in 2014. Its latest round of funding of $50m (£38m) took place in December 2019, bringing it to a £163m post-money valuation. Ogury confirmed its intention to expand internationally with this latest fundraising, after seeing a gap in the market for GDPR compliant technology, triggered by increasing concerns for privacy and data protection in the APAC region.
Its success in expanding overseas was recognised by the 2020 Fast Track International Track 200 high-growth list, which ranks mid-market private companies with the fastest-growing international sales over the most recent two accounting years. Ogury has featured on a further 10 high-growth lists since its inception.
International expansion is clearly a priority for Ogury, which of course requires considerable capital—we predict this will take the form of a megadeal in the near future.
Featurespace combines insights from data and computer science to develop artificial intelligence software that detects fraudulent behaviour. It achieves this by profiling customer activity and using machine learning to predict future individual behaviour. Its applications range from financial security, to anti-money laundering, to game fraud.
The AI company is a Cambridge University spinout, and attended the Future Fifty accelerator in 2018, a programme specifically focused on developing late stage technology businesses. Featurespace has so far been featured on no less than 15 high-growth lists, including being one of the recipients of the 2018 Queen’s Awards for Innovation.
Featurespace has secured a total of £83.5m equity investment across eight funding rounds–this happened roughly every 12 months since 2016, so it seems very likely that a new funding round is coming its way in 2021.
Build a Rocket Boy (no, not the Elbow album) develops AAA games. Founded by Grand Theft Auto lead developer Leslie Benzies in 2016, the company has grown at quite a pace. In 2017, Build a Rocket Boy opened an office in Budapest, away from its headquarters in Edinburgh and reached over 400 employees by 2020.
Having secured their series B funding in November 2020, the game developer raised £32.7m in equity funding co-led by Galaxy Interactive, together with existing investor NetEase. This round enabled Build a Rocket Boy to reach over £100m valuations and totalled their funding to £50m across four rounds.
The company’s success, despite the recent disruption caused by the pandemic, was evident in our research with the Telegraph back in 2020, where Build a Rocket Boy’s inclusion within the top 100 tech firms highlighted their positioning amongst the best and brightest in Britain’s startup scene.
The Scotland-based company is gaining interest due to the upcoming release of the game EVERYWHERE which is currently being worked on in their Edinburgh, Budapest and Los Angeles offices. New product launches are often accompanied by funding rounds, and we predict Build a Rocket Boy’s will be quite a successful one.
Oxford Photovoltaics, also known as Oxford PV, is a pioneer in the solar cell sector, generating more affordable clean energy whilst providing increasingly attractive solutions to tackling climate change. Established in 2010 by University of Oxford’s professor Henry Snaith and Kevin Arthur, the spin out has the vision to power the transition to an all-electric, greener, world.
The socially conscious Oxford PV’s growth comes at no surprise, growing from strength to strength since their inception, raising a total of £108m across 12 fundraising rounds, with the most recent round worth £34m in 2019 to enhance their transition into manufacturing and bring products to market.
Not only has Oxford PV experienced success in the funding department but the clean energy spinout has hit several of our growth triggers, evidencing their successful track record and optimistic future ahead. We can expect Oxford PV’s next move to be the complete installation of a new manufacturing line in their Brandenburg office, suggesting a potential need for fundraising.
Co-founded by Dr Mark Kotter and Florian Schuster, bit.bio (formerly Elpis Biomed) is a human synthetic biology company with ambitious targets including the aim to make new organs from cells within a decade.
bit.bio, much like Featurespace and Oxford PV is an academic spinout. Regarded as a market leader, bit.bio converges technology and biology to produce consistent batches of human cells.
bit.bio’s contributions to the regenerative medicine industry helped it secure two grants worth £280k and four rounds of equity fundraising totalling £35.9m. Funding has come from a multitude of stakeholders including Richard Klausner, former director of the National Cancer Institute and founder of Lyell Immunopharma, Juno and Grail.
bit.bio’s obvious focus on meeting its research goals in a sustainable manner makes it a key target for investors and a likely contestant for the next megadeal.
